Clinical Trial Update: Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity [Phase 1]

View source ↗

Summary

Phase 1 study investigating how reproductive cycle and menopause influence HIV-1 infection risk and the activity of topical tenofovir gel for prevention, with t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tenofovir Gel (tenofovir disoproxil fumarate (topical gel))

Snippet

Sponsor: CONRAD | Conditions: HIV Prevention | Phase 1 | Status: COMPLETED